Alternative Anticoagulants for Patients with Allergies to Both Warfarin and Rivaroxaban

Primary Alternatives

The American College of Cardiology recommends apixaban 5 mg twice daily as the strongest alternative to warfarin, demonstrating superiority with fewer strokes, systemic emboli, and major bleeding events in the ARISTOTLE trial of 18,201 patients 1, 2
Apixaban showed significantly fewer intracranial bleeds compared to warfarin, though gastrointestinal bleeding was similar, as reported by the Journal of the American College of Cardiology 2
Dabigatran 150 mg twice daily is an effective alternative for stroke prevention in nonvalvular atrial fibrillation with at least one additional risk factor, according to the American Family Physician 3, 1
The American Family Physician notes that dabigatran requires creatinine clearance >30 mL/min for the 150 mg dose, with dose reduction to 75 mg twice daily considered for CrCl 15-30 mL/min 3

The American Family Physician advises against using DOACs in patients with prosthetic heart valves or hemodynamically significant valve disease 3, 6
Advanced liver disease with coagulopathy is a contraindication for DOACs, as stated by the American Family Physician and Anaesthesia 3, 5

Unlike warfarin, DOACs do not require routine coagulation monitoring, but adherence is critical, as noted by Stroke and Gut 1, 4
Renal function must be monitored at least annually, as declining kidney function affects drug clearance and bleeding risk, according to the Journal of the American College of Cardiology and Gut 2, 4

Anaesthesia recommends stopping apixaban at least 48 hours before high-bleeding-risk procedures and 24 hours before low-bleeding-risk procedures 5
Bridging anticoagulation is generally not required during temporary DOAC interruption, unlike with warfarin, as stated by Anaesthesia 5

Idarucizumab specifically reverses dabigatran, as reported by Anaesthesia 5
Prothrombin complex concentrate (PCC) 50 IU/kg can be used for emergency reversal when specific agents are unavailable, according to Anaesthesia and Gut 5, 4

Aspirin alone (81-325 mg daily) is recommended only for patients who cannot take any oral anticoagulant, as advised by the American Family Physician 3, 6

The American College of Cardiology notes that apixaban has the strongest evidence for superiority over warfarin, while rivaroxaban only demonstrated noninferiority 1, 2
The American Family Physician warns against using combination antiplatelet therapy as a substitute for anticoagulation in high-risk patients, as it provides inadequate stroke protection 3, 8